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Summary 
Mutations in the PKD1 gene are the most common 
cause of autosomal dominant polycystic kidney dis- 
ease (ADPKD). Other PKDl-like loci on chromosome 
16 are approximately 97% identical to PKD1. To deter- 
mine the authentic PKD1 sequence, we obtained the 
genomic sequence of the PKD1 locus and assembled 
a PKD1 transcript from the sequence of 46 exons. The 
14.5 kb PKD1 transcript encodes a 4304 amino acid 
protein that has a novel domain architecture. The 
amino-terminal half of the protein consists of a mosaic 
of previously described domains, including leucine- 
rich repeats flanked by characteristic cysteine-rich 
structures, LDL-A and C-type lectin domains, and 14 
units of a novel 80 amino acid domain. The presence 
of these domains suggests that the PKD1 protein is 
involved in adhesive protein-protein and protein-car- 
bohydrate interactions in the extracellular compart- 
ment. We propose a hypothesis that links the predicted 
properties of the protein with the diverse phenotypic 
features of ADPKD. 
Introduction 
Autosomal dominant polycystic kidney disease (ADPKD) 
is one of the most common monogenic disorders in hu- 
mans, affecting 1 in 1000 individuals. Its major manifesta- 
tion is progressive cystic dilatation of the renal tubules, 
leading to renal failure in half of affected individuals by 
age 50. ADPKD is also associated with hepatic, pancre- 
atic, and splenic cysts, cardiac valve abnormalities, and 
an increased incidence of cranial aneurysms and sub- 
arachnoid hemorrhage (Gabow, 1990). 
Despite intensive investigation, the underlying biochem- 
ical defect in ADPKD remains unknown. A series of appar- 
ently unrelated abnormalities has been detected at the 
cellular and tissue levels both in ADPKD and in other forms 
of renal cystic disease. The most carefully documented 
of these findings are abnormalities in the composition of 
the tubular basement membrane, proliferation of tubular 
epithelial cells, and a reversal of the normal polarized dis- 
tribution of cell membrane proteins such as the Na÷/K ÷ 
ATPase (Wilson et al., 1986). 
Phenotypical!y indistinguishable forms of ADPKD are 
caused by mutations in three separate loci (Reeders et 
al., 1985; Kimberling et al., 1993; Peters et al., 1993). Two 
of these loci, PKD1 and PKD2, have been mapped to the 
short arm of chromosome 16 and chromosome 4, respec- 
tively. The third locus has not been mapped (Fossdal et 
al., 1993; Daoust et al., 1995). Mutations in PKDI account 
for approximately 90% of ADPKD cases. This locus pre- 
viously had been mapped to a gene-rich 500 kb interval 
in band 16p13.3 (Germino et al., 1992) that includes the 
TSC2 locus for tuberous sclerosis (TS) (Eu ropean Chromo- 
some 16 Tuberous Sclerosis Consortium, 1993). Some 
TS patients are known to develop renal cystic lesions that 
resemble those of ADPKD, which led investigators to ex- 
amine families with TS for positional segregation of 
ADPKD. One unusual family had members with polycystic 
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Figure 1. Schematic Representations of the 
PKD1 Genomic Region and the Full-Length 
PKDI cDNA 
(A) Schematic representation of the PKD1 ge- 
nomic region. The large bold numbers indicate 
the numbers of selected exons. The numbers 
outside of the semicircle denote the size of the 
introns. The small numbers inside the circle 
represent he size of the exons. Solid lines in- 
side the semicircle represent he cosmids from 
this region. N54T denotes a Notl site in 
oGGG10. The distance between exons 1 and 
2 is larger than 15,377 bp by at least 1000 bp. 
The distance between exons 22 and 23 is larger 
than 796 bp by at least 2000 bp. These repre- 
sent the genomic gaps not sequenced. 
(B) Schematic representation of the full-length 
PKD1 cDNA. The numbers above the rectan- 
gles indicate selected exons. Below is a physi- 
cal representation of the partial cDNAs de- 
scribed in the Experimental Procedures. 
kidney disease who were found to have inherited a bal- 
anced translocation ear the TSC2 locus, with a breakpoint 
in a novel gene named the polycystic breakpoint protein 
gene (PBP). PBP codes for a 14 kb m RNA (Eu ropean Poly- 
cystic Kidney Disease Consortium, 1994). Deletions and 
point mutations confined to the PBP gene confirmed its 
identity as the PKD1 gene (European Polycystic Kidney 
Disease Consortium, 1994; Schneider et al., 1994, Am. 
J. Hum. Genet., abstract), cDNA clones comprising the 
terminal 5.6 kb of the PKD1 transcript were found to con- 
tain an open reading frame (ORF) of 4.8 kb. Analysis of 
the deduced peptide encoded by the last third of the gene 
did not reveal any homologies to known proteins and, 
therefore, did not suggest a biochemical function for the 
product of the PKD1 gene. 
A major problem in the isolation and sequencing of the 
remaining part of the PKD1 gene has been the presence 
of several transcriptionally active copies of closely related 
PKDl-like sequences that map centromeric to PKD1 on 
chromosome 16p13.1 (European Polycystic Kidney Dis- 
ease Consortium, 1994). This has posed great difficulty 
in distinguishing the PKD1 locus transcript from those of 
the PKDl-like loci. 
Here we describe a strategy leading to the identification 
of the complete PKD1 gene sequence. We also provide 
the genomic structure of the gene and show that the mRNA 
transcripts are alternatively spliced. One form of the PKD1 
transcript encodes a 4304 amino acid polypeptide with 
five distinct extracellular peptide domains that are likely to 
be involved in protein-protein and protein-carbohydrate 
interactions. Although the PKD1 protein shares domains 
with a number of extracellular proteins, the combination of 
domains found in PKD1 has not been found in any known 
protein. 
Results 
A series of overlapping cosmid clones spanning the pre- 
dicted PKD1 genetic interval has been described (Germino 
et al., 1992). The integrity of the cosmid contig was con- 
firmed by long-range restriction mapping and genetic link- 
age analysis of polymorphic sequences derived from the 
cosmids. Three cosmids (cGGG1, cGGG10, and cDEB11 
from centromere to telomere) form a contig that includes 
the 3' end of TSC2 (cDEB11) and extends over 80 kb cen- 
tromeric to it. At the proximal end of cGGG10, there is a 
CpG island represented by a Notl site, N54T (Himmel- 
bauer et al., 1991) (Figure 1A). 
To identify transcripts from the region, the cosmid 
clones were hybridized to a set of five cDNA libraries. 
KG8, a cDNA clone containing the last 3.2 kb of the PBP 
sequence and located on cDEB11, was mapped by use 
of a panel of somatic cell hybrids and found to hybridize 
to a single locus on chromosome 16p13 (data not shown). 
Sequence analysis showed that KG8 contains the poly- 
adenylated 3' end of a gene and has an ORF of 2100 bp 
and a 1019 bp 3' untranslated region. KG8 was also found 
to contain a polymorphic microsatellite repeat (Snarey et 
al., 1994). Analysis of this repeat in a large number of 
PKD1 kindreds revealed no recombination in the disease 
locus (S. Somlo, unpublished ata). 
To obtain clones extending 5' of KG8, the cosmids 
cGGG10 and cDEB11 were hybridized to a series of differ- 
ent cDNA libraries (see Experimental Procedures). In Con- 
trast with KG8, when some of the resulting cDNA clones 
were analyzed using somatic cell hybrid panels (data not 
shown), they were found to hybridize strongly to several 
loci on chromosome 16 as well as to the PKD1 region. 
The restriction maps of the hybridizing loci were so similar 
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that we concluded that a series of recent duplications of 
part of the PKD1 gene had occurred (excluding the KG8 
segment) and had given rise to several PKDl-like genomic 
segments. 
Because of the high degree of similarity between PKD1 
and PKD1-1ike loci and because they all are transcription- 
ally active, it was not possible to determine the correct 
full-length PKDI cDNA sequence by assembling overlap- 
ping partial cDNA clones. To determine the sequence of 
the authentic PKD1 transcript, we sequenced cGGG10 
entirely and parts of cDEB11 containing PKD1 exons. 
Sequence of the Genomic Region of the 
PKD1 Locus 
The duplicated portion of the PKD1 gene is largely con- 
tained within the cGGG10 cosmid. Prior to sequencing 
cGGG10, we established the integrity of the clone in sev- 
eral ways. First, the restriction map of cGGG10 was com- 
pared with a map of the genomic DNA from the PKD1 
region and was found to be identical. Second, restriction 
maps of the overlapping portions of cGGG1 and cDEB11 
were compared with cGGG10 and were also found to be 
identical. Third, sequences derived from cGGG10 and 
overlapping portions of cDEB11 showed 100% identity. 
Finally, a P1 phage, PKD 1521, was obtained by screening 
a genomic P1 library with primers from the TSC2 gene. 
No sequence differences were observed between PKD 
1521 and cGGG10 in the regions sampled. 
Several approaches were taken to obtain the sequence 
of cGGG10 (see Experimental Procedures). A final 10-fold 
sequence redundancy was achieved for this cosmid in 
order to compare the genomic sequence accurately with 
that of the PKDl-specific and PKDl-like cDNAs (homolo- 
gous to this cosmid). The cGGG10 sequences were as- 
sembled into three contigs of 8 kb, 23 kb, and 4.4 kb, 
separated by 1 kb and 2.2 kb gaps (Figure 1). The cosmid 
cDEB11 was also sequenced and assembled to a 2-fold 
redundancy and compared with PKDl-specific cDNAs in 
order to obtain intron/exon boundaries of the unique 3' 
end of the gene. 
cDNAs from the PKD1 and the PKDl-like Loci 
To identify putative coding regions and intron/exon bound- 
aries, genomic and cDNA sequences were compared (see 
Experimental Procedures). When the sequences of over- 
lapping cDNAs were assembled, a transcript length of 14.5 
kb was obtained. The predominant transcript detected by 
Northern blot analysis using the unique sequence KG8 
probe is -14 kb (data not shown), suggesting that the 
cDNA clones represent he full length of the PKD1 tran- 
script. Restriction and sequence analyses indicate that a 
CpG island overlaps the 5' end of the sequence. CpG is- 
lands have been found to mark the 5' ends of many genes 
(Antequera and Bird, 1993). The most 5' cDNA clones 
(UN53, UN54, and UN59) all have identical 5'ends, provid- 
ing further evidence that no additional upstream exons 
were missed (see Experimental Procedures). 
The cDNAs used to assemble the PKD1 transcript, along 
with genomic exon/intron structure, are shown in Figures 
1A and lB. By comparing the sequences of overlapping 
cDNAs with the PKD1 genomic sequence, PKDl-specific 
cDNAs were distinguished from those encoded by the 
homologous loci (see Experimental Procedures). We iden- 
tified 46 exons and their exon/intron boundaries. The 
full-length transcript constructed from the genomic se- 
quence of the exons produces a large continuous ORF of 
12,912 bp. 
Alternative splicing of the primary PKD1 transcript is 
apparent from the sequences of the cDNAs. For this rea- 
son, we sought to isolate a minimum of two cDNAs con- 
taining each exon, thereby increasing the probability that 
all exons that contribute to the PKD1 transcript were de- 
tected. Despite this degree of coverage, it is possible there 
are PKD1 transcripts containing exons that are not present 
in any of the cDNAs we sampled. 
Exon 17 was found in two cDNAs (UN34 and BK156) 
and in cGGG10, but was not included in the final transcript 
for a number of reasons. First, the cDNAs in which this 
exon is found differed in sequence from the cosmid and 
are likely to represent PKDl-like genes (see Experimental 
Procedures). Second, this exon is not found in FK7 (a 
cDNA that was cloned by using a PKD/-specific probe; see 
Experimental Procedures), whose sequence is identical 
to the genomic sequence. Finally, when included in the 
full-length cDNA, this exon introduces a stop codon (743 
nt downstream of exon 17) that would produce a truncated 
protein of 2651 amino acids. We have recently identified 
an ADPKD patient with a heterozygous mutation that intro- 
duces a stop codon at position 10,601 of the ORF (Schnei- 
der et al., 1994, Am. J. Hum. Genet., abstract). Other mu- 
tations that truncate the PKD1 protein downstream of this 
exon have also been reported by the European Polycystic 
Kidney Disease Consortium. Therefore, it is unlikely that 
transcripts that include exons 17 are predominant forms 
in the kidney. Further studies are needed to determine 
whether this exon is included in other spliced forms of the 
PKD1 transcript. 
Sequence Analysis of the Predicted PKD1 Protein 
The assembly of 46 exons yields a predicted transcript of 
14.5 kb in length with 228 nt of 5' untranslated and 1019 
nt of 3' untranslated sequence. This transcript differs from 
the PBP sequence (European Polycystic Kidney Disease 
Consortium, 1994) because of the presence of two ex- 
tra cytosines at positions 12,873 and 12,874 of the ORF 
described in this paper (position 4563 of PBP). The poly- 
peptide encoded by the assembled transcript is 4304 
amino acids in length, with a predicted molecular weight 
of 462 kDa. 
The nucleotide sequence encompassing the putative 
Met-1 codon, CTAACGATGC, is an uncommon translation 
start site (Kozak, 1984). Nevertheless, this methionine is 
chosen as the probable start site because it is preceded 
by an in-frame stop codon 63 bases upstream. The PKD1 - 
coding region begins with a 23 amino acid sequence with 
many of the properties of a signal peptide and is followed 
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161 LAGOPLLGIP LLDSGCGEEY VACLpDNSSG TV~VSFS~ HEGLLQPSAC SAFCFS~ L~LSEQGWC ~QPSSA 240 
241 SFACLSLCSO PPAPPA~R GPTLLQ~FP ASPGATLVGP HGPLA~GOLA AFNTAAPLPV T~RWDFG~ SAEVD~CP t ~20 
321 ASHR~LPGR YHVTAV~LR A~ALLGTDV OVEAApAALE LVCPSSVQSD ESLDLSIQNR GGSGLEAAyS ZVALGEEPAR 400 
561 AQQ~LSAPH EPV~FPG LRLSAEAFLT TAS~TQELR RPAQLSLQW RLLSTAGTpE X~SEPESASP DNRTQLAP~ 640 
64& ~PCC~P~A STermLnA~C ~OAC~CT SGPGLPGAPY ALWSEFLFSV #AGPPAQYSV TL~GOD~ML PGDLVGLQHD 720 
72; AGPGALLHCS PA~HPGP~ pyLS~A£SW LPHLPAQLEG TWGCPACALK LLAQREQLTV "LLGLRPN~L ELPGBYEV~ 800 
801 ~G~VS~a~ LSCSFDWS~ VAGL~VZYeA p~C~RLW~ N~SALVLOVa SC~ATA~A~ W~CSLSARF SNVCpAUV~T 880 
881 FV~aCp~S~N D~L~SW~ ~LSEGSRWD VVVSaSAS~ NLSSRWAS~ ~ZC~L~A~?S ~S~VLQOVS WYS#W~AC 9e0 
961 SD~FRWTIN OKQSLTFQ~ VF~IYOS~ VFKLSLTASN HVS~YN VTVSR~NMQ GLQVSTVPAV LSPNATLAL~ 1O40 
128l ~HI.AR~L~L V~LEVLRV¢ ~CTP~PD ARLTAWCGN PA~YT;~r  G~R~NTT~ ~CpTVTHNV~ RR~FPI,ArV &360 
136l LSSR~AMY ~T~ICVEPEV G~T~p~RO Fvm,cn~AWL VACAWPpFPY RYTWDFGTEE ~pTRAROP~ VTF IYRD~ 1440 
1601 FR~VGTFNII VTA~N~GSA ODSIFVYVLQ LIEGSQWSS G~YFP~NRTV OLOAWRD~,~ ~YS~AWR DRGpATae~G 1680 
1841 V~SSXRGP HV~FPDAG TFSIRLNA~N AVS~SATYN LTAEEpIVGL VLWASSKVVA ~OrV~OIL  L~CSAV~FR 1920 
1921 ~VGG~PEV LPGPRPSHSF PRVGDHWSV BG~N~AO AOVR~EA VSGLQVpNCC SPGIATGTER NFTARVORCS 2000 
2001 RVAYAWYFSL OEV~DS[,VT LSGRDVTY'PP VAA#I;~TOV RAFNATCRRN R?T.VI,EVODA VQYVALQSGP CFTNRSAO~R 2080 
2081 AA~RPRPRRV AYHWQ?~ P~O~TDEPRA RM~YLRPGDY RVO~A~NLV ~PVAOA?VT VOVLACREPE ~WLPLQVL 2160 
2161 MRRSQRNYLE AHVDLRDCVT YQTEY~WE%~ RTASCQRPGR £ARVALPGVD VSRpRLVLPR LALPVGHYCF VFVVSFGDTp 2240 
224l LTOSIQ~T VAPERLVPIZ EGGSYR~SD TRDLVL~SE SYDPNLEDGD QTPLSFHWAC VASTQR~GG CALNFGP~GS 2320 
2321 STVTIPRERL ~GVEYTFSL T%~KAGRKEE ATNQTVLZRS GBVP~VSL~ VSCKAQA~E VSRSSYWLE GRCLNCS~GS 2400 
2401 KRGRW~TF SNKTLVLDET TTSTGSAGMR LVLRRGVLAD GEGY~FTL~ ~RSGEEEGC ASIRLS~RP F~SCRI~Fp 2480 
2481 LGAVHALT~K V~FEC~WHD AED~GAPSW ALLLRRC~QG RCEEPCWKG SLSSYGAVLP PGFRPHF~G ~QDQLG 2560 
2561 ~WALN~SL AITLPEPNGS ATGLT~LHG LTASVL~LL RQ~POHVIE YS~LV~LN EYERALDV~ CPKHERON~ 2640 
2641 QIRKNITETL VSLRVH~DD ZQQI~LAQ CMGPSRELVC RSCLKQTLHK SE~L ILQA ETTAGTWpT AIGDSILaIT 2720 
272~ GDLIHLASSD VRAPQPSELG AESPS~AS QAYHLTSALM RIL~SRVLN E~PLTLAGEE IVA~KRSDP RSLLCyG~Ap 2800 
2801 G~CHFSIPE  AFSGAL~LS D'~QL~FLVD SNPFPFGyIs NYTV~TKVAS ~F~AGAQ IpIERLASER A ITVKVP~S 2880 
2881 ~SGHRSS A~SANSVVVQ pOASVGAWT LDSSN~MCL HLQSNYTLLD GHYLS~EP~P ySAWLHSEP RPNEHNCSAS 2960 
2961 RRIBPESL~ ADHRPYTFFZ SPGSRDPAGS YHLNLSSHFR WSA~VSVGL YTSLCQYFSE ED~RTEGL LPLEETSPRQ 3040 
304l AVCLTRHLTA FGASLFVPPS H~FPEPT  ADV~yZVMLT CAVCLVTyMV MAAILHKLDO LDASRGRAIP FCGQHGRFKy 3120 
3t21 EZLVKTG~R G£GTTAHVG; MLYGVDSRSG HRHLDGDR~ H~BLDIFRI ATpHSLG$~ KIRV~DNKG LSPAWFLQHV 3200 
3201 IVEDLQTARS AFFL~DWLS V~E~OOLV EKEVLMSDA ALLRPRRLLV AELQRGFFDK HZWLSZWDRP P~SR~RIQR 3280 
3281 ATCCVLLICL F~A~YG AVGDSAYS~ ~SBLSPLSV ~AVGLVSS ~PVYLA I  LFLFRMSRSK VAGSPSPTPA 3360 
3361 CQQVLDIDSC LDSSVLDSSF LTFSGLHAEQ AFVGQMKSDL FLDD~KSLVC WPSGEGTLSW PDLLSDPSIV GSNLRQL~G 3440 
3441 QAGHGLGPEE ~FSLASPYS PAKSFSASD£ DLZQQVLAEG VSSPApTQ~ ~ETDLLSSL SSTPGEKTET LALQR~E~ 3520 
3521 PPSpG~EQ pQ~RLSRTG LVEGLRKRLL PANCASL~G LSLLLVAVAV AVSGWGASF PPOVSVBWLL SSSASFLASF 3600 
3601 LGWEPLKVLL EALYFSLVAK RLHPDZDDTL VESPAVTPVS ARVPRVRPPH GFALFLAKE~ ARKVKRLHGM LRSLS~LF 3680 
3681 LLVTL~SY6 DASCHGHAYR LQSAIKQELH SRAFLAITRS EELW~AHV LLP~HGNQS SPELGPPRLR Q~EALyp 3760 
8761 DPPGPRVH'rC SAACGFSTSD YDVGWESPHN GSGTWAYSAP DLIX;AWSW3S CA%~DSGGYV QELGLSLEES RDRSRFLQLH 3840 
3841 ~LDNRSRAV FLELTRYSPA VGLHMVTLR LEFP~G~L ~LS~PFAL  RRLSAGLSLp LLTSVCLLLF A~FAVA~R 3928 
3921 TWHR~R~V LRLGAW~WL LVALT~TAL VRLAQLG~D R~RFVRGR PRRFTSF~V AHVSS~RGL ~SLLFLLLV 4000 
4001 K~Q~RFVR QWSVFGKT~ ~LPELLG~ LGL~GVAY AQLAyLLVSS CVDSLWSVAQ ALLVLCPGTG LST~PAESW 4080 
4GSl HLSPLLCVGL WALRL~ALR LGAVILR~Y H~RGELYRP A~PQDy~ ELFLRRLRLW NGLSKVKEFR HKVRFEGMEp 4160 
4161 LPSRSSRGSK V;pDvPPpSA GSDASHPSTS SSQL~LSVS LGE~TRCEP EPSRLQAVFE ALLTQFDaLN QATED~0LE 4240 
424l QQLHSL~R~ $SRAPAGSSR GPS~LRPAL PSRLA~SRG ~LA~PSRT PLR~p SSTZ 4304 
Figure 2. PKD1 Open Reading Frame 
The different domains are underlined. See text. 
by a predicted cleavage site (von Hejne, 1986) (Figure 2). 
In addition to the signal sequence, the identification of five 
domains that have been identified in other extracellular 
proteins strongly suggests the extracellular location of at 
least the amino-terminal half of the protein. 
Immediately downstream of the signal sequence, there 
are two leucine-rich repeats (LRRs) (Figure 2). These 
LRRs (in exons 2 and 3) are flanked on both sides by 
cysteine-rich regions that have homology to the flanking 
regions of a subset of other LRRs. LRRs occur in numer- 
ous proteins (Figure 3) and have been shown to be in- 
volved in diverse forms of protein-protein interaction. The 
number of LRRs within the respective proteins varies be- 
tween 2 and 29 (Kobe and Deisenhofer, 1994). Adhesive 
platelet glycoproteins form the largest group in the LRR 
super'family (Kobe and Deisenhofer, 1994). The structure 
of the array of 15 LRRs in porcine ribonuclease inhibitor 
(RI) has recently been determined (Kobe and Deisenhofer, 
1995); the LRRs form a horseshoe-like structure that sur- 
rounds and binds to RNase A (Kobe and Deisenhofer, 
1995). It has been suggested that proteins containing only 
a few LRRs, such as the PKD1 protein, interact with other 
proteins via the LRRs in order to form the horseshoe-like 
superstructure for protein binding (Kobe and Deisenhofer, 
1994). 
Although LRRs occur in various locations in different 
proteins, the additional flanking cysteine-rich domains de- 
PKDI  exor  2 LDVSHNLL~LALDVGLLANLSALAE 
-=KDI exon  2 LD ISh~KISTLEEGIFANLFNLSE 
ALE  ~ H '=~an LI~L ER~QLRS LSAGTFAHT PALAS 
C~= ~ =_ ' H -~ an  LS  LQWNMLRVL PAGLFAHTPCLVG 
T r kA /H-~man LVL  SGNOLHCSCALRWLQRWEEEG 
A2GL/H '~,an  LDL  SGNRLRKLP  PGLLANFTLLRT 
GP IA /Hunan LDVS FNRLTSL  P LGALRGLGELQE 
HSGPV/H,~ a n L FLDHNALRG I DQNMFQKLVNLVN 
Garp  / H~-~an L DLSGNQLRS I LAS  PLGFYTSLRH 
O VpG iHuman '/DL S~JS  LTQI  LPGTL INLTNLTN 
PGS21 H:~an LGL  S FNS I SAVDNGSLANTPHLRE 
5U~G/Human LELASNHFLYLPRDVLAQL PS  LRH 
S i i% / P ros  i LYLESNEIEQIHYERIRHLRSLTR 
To l i /Dros  LDLSNNRLTHL PDSLFAHTTNLTD 
LD S N L L G ANL  L E 
Figure 3. LRRs 
LRRs are coded by exons 2 and 3 on the PKD1 transcript. Examples of 
proteins that also contain LRRs are human insulin-like growth factor- 
binding protein complex acid-labile chain precursor (ALS); human car- 
boxypeptidase 83 kb chain (CBP8); human high affinity nerve growth 
factor receptor (trkA); leucine-rich ~z-2-glycoprotein (A2GL); platelet 
membrane glycoprotein 1B a chain precursor (GPIA); platelet glyco- 
protein V precursor (HSGPV); human garp gene product (garp); human 
oligodendroc~e-myelin glycoprotein precursor (OMPG); human bone 
proteoglycan, decorin (PGS2); human 5T4 oncofetal antigen (ST4G); 
and Drosophila slit and Toll proteins. Conserved amino acids are repre- 
sented in the bottom line of the figure. 
fine a subgroup of extracellular proteins (Kobe and Deisen- 
hofer, 1994). Only a few proteins contain both the distinct 
amino-terminal and carboxy-terminal flanking cysteine- 
rich domains (Figures 4 and 5). Among this group are Toll, 
slit, Trk, TrkB, and TrkC. This set of proteins all have intra- 
cellular domains that could relay signals to the cytoplasm. 
For example, the Drosophila Toll protein is required for 
mediating dorsoventral patterning (Hashimoto et al., 
1988). The Drosophila slit protein is believed to mediate 
interactions between growing axons and the surrounding 
extracellular matrix (Rothberg et al., 1990). In vertebrates, 
these domains are found in the Trk family of tyrosine ki- 
nase receptors (Schneider and Schweider, 1991); the 
platelet glycoproteins I and V, which mediate the adhesion 
of platelets to sites of vascular injury (Roth, 1991); and 
the 5T4 oncofetal trophoblast glycoprotein, which appears 
to be highly expressed in metastatic tumors (Myers, 1994). 
The PKD1 protein also contains a single domain with 
homologies to C-type (for calcium-dependent) lectin pro- 
teins (Drickamer, 1988) (see Figure 2). These domains 
are believed to be involved in the extracellular binding 
of carbohydrate residues for diverse purposes, including 
internalization of glycosylated enzymes (asialoglycopro- 
tein receptors) and cell adhesion (selectins) 0Neis, 1992). 
The classification of C-type lectins has been based on 
exon organization and the nature and arrangement of do- 
mains within the protein (Bezouska et al., 1991). For exam- 
ple, class I (extracellular proteoglycans) and class II (type II 
transmembrane receptors) all have three exons encoding, 
the carbohydrate recognition domain (CRD), whereas in 
classes III (collectins) and IV (lectin cell adhesion mole- 
cules [LEC-CAMs]), the domains are encoded by a single 
exon. The C-type lectin CRD in the PKD1 protein does 
not fit into the above classification, because it has a novel 
combination of protein domains and because it is encoded 
by two exons (exons 6 and 7; Figure 6). Previous analysis 
has failed to establish a correlation between the type of 
carbohydrate bound to each C-type lectin and the primary 
structure of its CRD 0Neis, 1992). 
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PKDI  exon  1 
ALS/HUman 
TrkA/Human 
GP iB /Human 
OMGP/Human 
HSGPV/Human 
PGS2/HLunan 
S l i t /Dos  
To l l /Dros  
PCEPFCLCGP APGAACRVNCSG RGLRTLGPALRI  
ACPAACVCSYDDDADELSVFCSSRNLT- -RLPDGVPGGTQA 
QCPALCECS . . . .  EAARTVKCVNRNLT- -EVPTDLPAYVRN 
GCPAPCSCA . . . . .  GTLVDCGRRGLTWASLPTAFPVDTTE 
ICPLQCICTE-  - -BHRHVDCSGRNLS- -TLPSGLQENI IH  
PCPPACKCV- -= FRDAAQCSGGDVA- -B ISA  LGLPTNK 
VCPFRCQCH . . . . . .  LRWQCSDLGLD- -KVPKDLPPDTTL  
SCPHPCRCA . . . .  DGIVDCREK~LT- -SVPVTLPDDTTD 
KCPRGCNCHVRTYDKALVINCHSGNLT==HVPR-LPNLHKN 
C CC C L 
Figure 4. Amino-Terminal Cysteine-Rich Domain 
This repeat is encoded by exon 1 in the PKD1 transcript. Examples of 
proteins that also contain these repeats are human insulin-like growth 
factor-binding protein complex acid-labile chain precursor (ALS); hu- 
man high affinity nerve growth factor receptor (trkA); platelet mem- 
brane glycoprotein 1B ~ chain precursor (GP1B); human oligodendro- 
cyte-myelin glycoprotein precursor (OMPG); platelet glycoprotein V 
precursor (HSGPV); human bone proteoglycan, decorin (PGS2); and 
Drosophila slit and Toll proteins. Conserved amino acids are repre- 
sented in the bottom line of the figure (conserved amino acids are not 
aligned). 
Exon 10 encodes a low density lipoprotein A (LDL-A) 
module (see Figure 2), a cysteine-rich domain of about 40 
amino acids in length. This module was originally identified 
in the LDL receptor (Sudhof et al., 1985), but it is also 
present in the extracellular portion of many other proteins, 
often in tandem arrays (Bork and Bairoch, 1995) (Figure 
7). Because of their hydrophobic nature, these domains 
have been implicated as ligand-binding regions in LDL 
receptor-related proteins (Krieger and Herz, 1994). 
In addition to the five extracellular protein modules that 
have been recognized previously, the PKD1 protein con- 
tains 14 copies of a novel domain of approximately 80 
amino acids (see Figure 2). We named this domain the 
PKD domain. The first such domain is encoded by exon 
5 between the LRRs and the C-type lectin module. The 
other 13 PKD domains are arrayed in tandem, starting 
at amino acid 1031 and ending at amino acid 2142 and 
contained in exons 13, 14, and 15. Profile and motif 
searches (see Experimental Procedures) identified sev- 
eral other extracellular proteins that also contain one or 
more copies of this novel domain. The PKD domains are 
unusual in that they are found in the extracellular parts of 
proteins from higher organisms, eubacteria, and archae- 
bacteria. In general, extracellular modules of proteins from 
higher organisms are not found in bacteria. The few excep- 
tions appear to be the result of horizontal gene transfer 
(Doolittle and Bork, 1993) (Figure 8). The animal proteins 
containing an individual PKD domain are heavily glycosyl- 
ated, melanoma-associated cell surface proteins, such as 
melanocyte-specific human Pme117 (Kwon, 1993), the 
PKDI exon 4 SGNPFECDCGLAWLPQWAE~-QQVRWQPE- - -  AATCAGPGSLAGQPLLGIP=LLDSGCG 
ALS/Human EGNPWDCGCPLKALRDFALQN- - PSAVPRFV - - = QA I CEGGDDCQp FAYTYN- - - - NITCA 
TrkA/Human SGNPLHCSCALRWLQBWEE~ - GLGGVPEQ . . . .  KDQCHGQGPLAHMP . . . . . . .  NASCG 
A2CL/Human SGN PWI CDQNLSDLYRWLQA-QKDKMFSQN .... DTRCAGpEAVKGQTLLA - - - - VVAKSQ 
HSGPV/Human GHNSWRCD(~GLGPFt~GWLRQ- ~ HLGLVGGEE - pPRCAGPGAHAGLPLWALPG ~G DAEC P 
5T4G/Human DNN PWVC PC HMADMVTWLK~ - - TEVVQGKD - - RLTCAYpEKMRNRVL ELNS -ADLDCD 
Slit/Dros] S DNPFACDCHLSWLSRFLRS - -ATRLAPY .... TRCQS PSQLKGQNVADLHD - QEFKCS 
Tol i/Dros NDNPLVCDCTLLWFVQLVRGVHKPQYSRQFKLRTDRLVCSQpNVLEGTPVRQI~P TLICP 
ttNPh CDC£L h hht C £P~ hit CE 
Figure 5. Carboxy-Terminal Cysteine-Rich Domain 
This repeat is encoded by exon 4 in the transcript. Examples of other 
proteins that contain these domains are also listed, such as human 
insulin-like growth factor-binding protein complex acid-labile chain 
precursor (ALS); human high affinity nerve growth factor receptor 
(trkA); leucine-rich a-2-glycoprotein (A2GL); human heparin sulfate 
glycoprotein V (HSGPV); human 5T4 oncofetal antigen (5T4G); and 
Drosophila slit and Toll proteins. The hydrophobic and turn-like or 
polar amino acids are denoted by h and t, respectively. Conserved 
amino acids are represented inthe bottom line of the figure. 
melanosomal matrix protein (MMP) 115 protein (Mochii et 
al., 1991), and the Nmb protein (Weterman et al., 1995). 
The physiological functions of these glycoproteins remain 
to be elucidated. Four eubacterial extracellular enzymes, 
including three distinct collagenases (Yoshihara et al., 
1994) and lysine-specific Achromobacter protease I (API), 
also contain a single copy of the domain adjacent o their 
catalytic domains. Four copies of the PKD domain are also 
present in the heavily glycosylated surface layer protein 
(SIpB) from Methanothermus (Brockl et al., 1991; Yao et 
al., 1994). 
The PKD domain is predicted to be a globular domain 
that contains an antiparallel 1~ sheet. Although the PKD 
domains do not contain conserved cysteines, we believe 
they are extracellular domains, first because all homolo- 
gous domains are extracellular; second, because the first 
such domain in PKD1 (amino acids 281-353) is located 
between other known extracellular modules; and third, be- 
cause there are no predicted transmembrane regions be- 
tween the other identified (extracellular) modules in PKD1 
and the 13 remaining PKD domains. Whereas the PKD 
domains in SIpB are very similar (Brockl et al., 1991), point- 
ing to a rather recent duplication, the 14 domains in PKD1 
are quite divergent. Even the most conserved (WDFGDG) 
motif is considerably modified in some of the PKD domains 
(Figure 8). Therefore, it is unlikely that unequal recombina- 
tion between genomic sequences encoding these do- 
mains is a common source of mutations in this disease. 
In the carboxy-terminal half of the protein, we found re- 
gions of similarity to a putative Caenorhabditis elegans 
protein (GenBank accession number Z48544) encoded by 
PKDI  exons  6 /7  
Reg I I /Human 
Hotb /Human 
Hanr /Human 
Lec /Rat  
P ro tc /Ch icken  
Lec3/Megro  
PKDI  exons  6 /7  
Reg I I /HUman 
Botb /Human 
Manr /Human 
Lec /Rat  
P ro tc /Ch icken  
Lec3/Megro  
LCPSDTEIFPGNGHCYRLVVEKAAWLQAQ=-EQCQ-AWAGAALAMVDSPAVQRFLVSRV . . . .  TRSLDVWIG 
SCPE- -GSNAYSSYCYYFTEDRLTWADAD- -LFCQ-NMNSGYLVSVLSQAEGNFVASL IKESGTTDANVWTG 
DCPP- -DWSSYEGHCYRFFKEWMHWDDAE- -EFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLKGDV-VWIG 
HCPS -QWWPYAGHCYKI -HRDEKKIQRDALTTCR- -KEGGDLTS IHT IEELDF I ISQL- -GYEPNDELWIG 
CCP I -  NWVEYEGSCYWFSSSVKPWTEAD -KYCQ- -LENAHLV~SWEEQRFVQQHM . . . .  GPLNTWIG 
NCEE- -GWIKFQGHCYR-=HFEERETWMDAESRCR- -EHQAHLSSI ITPEEQEFVNSH . . . . . .  AQDYQWIG 
TCPGNLDWQEYDGHCYWASTyQVRWNDAQ- -LACQTVHPGAYLAT IQSQLENAF ISETV . . . . .  SNNRLWIG 
CP  GHCY tW A Ct  t tA  L h o tFh  t t WIG 
FSTVQGVEVGPAPQGEAFSLESCQNWLPGEPHPA- -TAEHC~'RLGP . . . .  TGWCNTDLCSAPHSYVCELQP 
LHDPKRNRRWHWSSGSLFLYK- - -SWATGSPNSS-NRG-YCVSLTSN- -TGYKKWKDDNCDAQYSFVCKFKG 
LSDVWNKCRFEWTDGMEFDYD- - -DYYL IAEY  . . . . . . .  ECVASKP . . . .  TNNKWWI IPCTRFKNFVCEFQA 
LNDIK IQMYFEWSDGTPVTFT- - -KWLRGEPSHENNRQEDCVVMKG . . . .  KDGYWADRGCEWPLGYICKMKS 
LTDQNGPWKWVDGTDYETGFK-  -NWRPGQpDDWYGHG-LGGGEDCAHFTTDGHWNDDVCRRPYRWVCETEL  
LSDRAVENDFRWSDGHSLQFE- - -NWRPNQPDNFFSAGEDCVVMIWH- - -EQGEWNDVPCNYHLPFTCKKGT 
LNDIDLEGHYVWSNGEATDFT- - -YWSSNNFNNW-:ENQDCGVVNYD -TVTGQWDDDDCNKNKNFLCKMPI  
L t t  h t tG  h ht  W tP  CV G W Ct  tahCtht  
Figure 6. C-Type Lectin Domain 
This repeat is encoded by exons 6 and 7. Exam- 
ples of other proteins that contain these re- 
peats are also listed, such as human regenerat- 
ing islet cell factor (Regll); human botrocetin 
(Botb); human mannose receptor (Manr); rat 
C-lectin (Lec); chicken proteoglycan core pro- 
tein (Protc); and barnacle lectin BRA3 (lec3). 
The hydrophobic and turn-like or polar amino 
acids are denoted by h and t, respectively. Con- 
served amino acids are represented inthe bot- 
tom line of the figure. A lowercase letter orepre- 
sents serine, threonine, or both; a lowercase 
letter a represents aromatic amino acids. 
Cell 
294 
PKDI  exon  i0  
Entero l /P ig  
AM2/mouse  
LDLre l l /Ceano .  
HSPG/Human 
CScom/Human 
ACMPGGRWCPGANICLPLDASCHPQ ACANG . . . . . . .  CTS  
ECLPGSRPCADALKCIAVDLFCDGELNCPDGSDEDSKICAT 
RCPPNEHSCLGTELCVPMSRLCNGIQDCMDGSDEGA-HCRE 
RCPPGKWNCPGTGHCIDQLKLCDGSKDCADGADEQQ- -CSQ 
PCGPQEAACRNGH-C IPRDYLCDGQEDCEDGSDELD ~CGP 
RCEG- -FVCAQTGRCVNRRLLCNGDNDCGDQSDEAN- -CRR 
tC  t C t t  Ch  LCtG tC  DGSDE t C t 
Figure 7. LDL-A Domain 
The LDL-A domain is encoded by exon 10. Examples of other proteins 
that contain these domains are also listed, such as pig enterepepti- 
dase, mouse AM2 receptor, C. elegans LDL-related receptor, human 
basement membrane proteoglycan (HSPG), and human C8 comple- 
ment ~ chain. The turn-like or polar amino acids are denoted by t. 
Conserved amino acids are represented inthe bottom line of the figure. 
chromosome III (Wilson et al., 1994). The differences in 
the amino termini of these proteins imply that they are 
paralogs (i.e., not the equivalent genes in different spe- 
cies) and thus hint at the presence of a multigene family. 
Between positions 3986 and 4040 there are several hy- 
drophobic regions that might represent possible trans- 
membrane domains, but without any clear resemblance 
to other such domains. Since the overall architecture of 
the PKD1 protein does not resemble other known proteins 
in which membrane domains are present, future indepen- 
dent data will be required to determine whether this seg- 
ment spans the cell membrane. 
Discussion 
We report the DNA sequence and deduced protein se- 
quence of PKD1, the gene that is commonly mutated in 
autosomal dominant polycystic kidney disease (ADPKD). 
The sequence presented in this paper extends the pre- 
viously published partial sequence (by 2689 amino acids) 
and shows that the PKD1 gene encodes a 4304 amino 
acid protein whose amino-terminal portion is made up of 
a series of extracellular protein domains. Since these do- 
mains are present in a combination that has not been seen 
in other multidomain proteins, the product of the PKD1 
gene cannot be assigned to an existing protein family. The 
recognizable modules include two leucine-rich repeats 
flanked by cysteine-rich domains, a C-type lectin carbohy- 
drate recognition domain, an LDL-A domain, and a novel 
80 amino acid domain present both as a single unit and 
separately as a tandem array (Figure 9). 
In view of its enormous length and the presence of multi- 
ple adhesive domains, the PKD1 protein appears to be a 
multifunctional protein that is involved in various protein- 
protein and protein-carbohydrate interactions in the extra- 
cellular compartment. The presence of several distinct 
binding domains suggests that the PKD1 protein binds 
to more than one molecule or to several parts of a large 
extracellular molecule. It is unclear whether the PKD1 pro. 
tein contains a cytoplasmic segment or whether the pro- 
tein is wholly extracellular. Nevertheless, the structure of 
the PKD1 protein suggests that it binds to components of 
the extracellular matrix or to cell membrane-associated 
proteins. Therefore, the PKD1 protein may mediate cell- 
cell or cell-matrix interactions, or may itself be an intrinsic 
component of the extracellular matrix. 
Although a number of defects have been observed at 
both the cellular and the tissue levels in ADPKD and in 
rodent models of renal cystic disease, it has been unclear 
whether they represent primary or secondary events (Calvet, 
1993; Carone et al., 1994). One such defect is the abnor- 
mal distribution of cell membrane components between 
the apical and the basolateral surfaces of the polarized 
tubular epithelium. For example, Na÷/K ÷ ATPase is found 
on the basolateral surface of normal tubules and nondi- 
lated tubules in ADPKD samples, but is present on the 
apical surface of cystic epithelia (Wilson et al., 1991). It 
has been suggested that mislocalization of membrane pro- 
teins results from a defect in protein sorting. However, the 
structure reported her e makes it unlikely that the PKD1 
protein is involved in the primary sorting of proteins (Car- 
one et al., 1994). 
Another hypothesis is that the PKD1 gene encodes a 
growth factor or growth factor receptor and that mutations 
in the PKD1 gene result in epithelial proliferation (Gran- 
tham, 1990; Wilson et al., 1986). An increase in the number 
of cells lining the tubules inevitably leads to dilatation in all 
PKDI  exon  5 R1  
PKDI  exon  13 R2 
PKDI  exon  14 R3 
PKD1 exon  15 R4  
PKDI  exon  15  E5  
PKDI  exon  15  R6 
PKDI  exon  15 R7 
PKDI  exon  15  R8 
PKDI  exon  15 R9 
PKDI  exon  15 R I0  
PKDI  exon  15 E l l  
PKDI  exon  15 E l2  
PKDI  exon  15 R I3  
PKDI  exon  15 R I4  
Pmel /Human 
Pmel /Bov ine  
Nmb/Human 
Co l l /V iba l  
S lpb /Meth l  
S lpb /Meth2  
S lpb /Meth4  
Co ly /C lope  
Ap i /Ach ly  
GPLASGQLAAFHIAAPLPVTDTRWDFGDGSA . . . . . .  EVDAAGPA . . . . . . . . . . . .  ASHRYVLPGRYHVTAVLALQAG-SALLGTDVQVE 
SPNATLALTAG•LVDSAvEVAFLWTFGDGEQALHQFQPPYNESFPvPDPSVAQVLVEHNVTHTYAAPGEYLLTVLASNAFE-NLTQQVP•SVR 
VAGRPVTFYPHPL-PSPGGVLYTWDFGDGSP . . . . . .  VLTQSQPA . . . . . . . . . . . . .  ANHTYASRGTYHVRLEVNNTVS-GAAAQADVRVF 
AVEQ~APVVVSAAVQTGDNITWTFDMGDGT . . . . . . . . .  VLSGPEAT . . . . . . . . . .  VEHVYLRAQNCTVTVGAGSPAG-HLARSLHVLVF  
IPTQPDARLTAYVTGNPAHYLFDWTFGDGSSN . . . . . .  TTVRGCPT . . . . . . . . . . . . .  VTHNFTRSGTFPLALVLSSRVN RAHYFTS ICVE 
FVQLGDEAWLVACAWPPFPYRYTWDFGTEEA . . . . . .  APTRARGPE . . . . . . . . . . . . .  VTF IYRDPGSYLVTVTASNNIS-AANDSALVEVQ 
LGLELQQPYLFSAVGRGRPASYLWDLGDGG . . . . . . . . .  WLEG-PE  . . . . . . . . . . . . .  VTHAYNSTGDFTVRVAGWNEVS-RSEAWLNVTVK 
WPLNGSVSFSTSLEAGSDVRYSWVLCDRCT . . . . . . . .  P IPGGPT . . . . . . . . . . . . .  ISYTFRSVGTFNI IVTAENEVG-SAQDSIFVYVL  
YFPTNHTVQLQAV~DGTNVSYSWTAWRDRG . . . . . .  PALAGSGKG . . . . . . . . . . .  FSLTVLEAGTYHVQLRATNMLG-SAWADCTMDFV 
PAAVNTSVTLSAELAGGSGVVYTWSLEEGLS . . . . . . . .  WETSEPF  . . . . . . . . . . . . .  TTHSFPTPGLHLVTMTAGNPLG-SANATVEVDVQ 
FVAAGSSVPFWGQLATGTNVSWCWAVPGGSS . . . . . . . .  KRGPH . . . . . . . . . . . .  VTMVFPDAGTFS IRLNASNAVS-WVSATYNLTAE 
WAPGQLVHFQILLAAGSAVTFRLQVGGAN . . . . . . . .  PEVLPGPR . . . . . . . . . . . . .  FSHSFPRVGDHVVSVRGKNHVS-WAQAQVRIVVL  
G IATGTEP~NFTARVQRGSRVAYAWYFSLQKVQG- -  DSLV ILSGRD . . . . . . . . . . . . .  VTYTPVAAGLLE IQVRAFNALG-SENRTLVLEVQ 
FTNRSAQFEAATS~PSPRRVAYHWDFGDGSP . . . . . . .  GQDTDEPR . . . . . . . . . . . . .  AEHSYLRPGDYRVQVNASNLVS-FFVAQATVTVQ 
PLTFALQLHDPSGYLAEADLSYTWDFGDSSG . . . . . . .  TL ISRAPV . . . . . . . . . . . . .  VTHTYLEPGPVTAQVVLQAAIP -LTSCGSSPVPG 
PLTFALQLHDPSGYLAGADLSYTWDFGDSTG . . . . . . .  TL ISRALT  . . . . . . . . . . . . .  VTHTYLESGPVTAQWLQAAIP -LTSCGSSPVPG 
P IMFDVL IHDPSHFLNYST INYKWSFGDNTG . . . . . . .  LFVSTNHT . . . . . . . . . . . . .  VNHTYVLNGTFSLNLTVKAAAP- -GPCPPPPPPP  
VGESITFSSENSTDPNGKIVSVLWDFGDGST . . . . . . .  STQTKPT . . . . . . . . . . . . .  HQYGSEGEYSVSLSVTDSEG-LTATATHTVVI  
TSGTAPLNVLFTDTSTGSPTTW~WNFGDGT$ . . . . . . . .  STQKSPT . . . . . . . . . . . . .  HAYSTAGTYTVTLTVTNSAGSNTATKTNYVTV 
RSGIAPLTVTFKDNSSGSPTAWNWSFGDGAY . . . . . . .  SNEKYPK . . . . . . . . . . . . . . .  HTYTAPGSYT ISLTASNAAGSNTLTKSNYI~ 
RSGTAPLTVTFKDNSSGSPTAWNWSFGDGAY . . . . . . . .  SNEKYPK . . . . . . . . . . . . . . .  HTYMAPGSYT ISLTASNAAGSNTL IKNNYIVV 
VEEE INFDGTESKDEDGEIKAYEWDFGDGEK . . . . . . . .  SNEAKAT . . . . . . . . . . . . . .  HKYNKTGEYEVKLTVTDNNG-GINTESKKIKV 
SGLTATFT-DSSTDSDGSIASESWNFGDGST . . . . . . . .  STATNPS . . . . . . . . . . . . .  KTYAAAGTYTVTLTVTDNGG-ATNTKTGSVTV 
hh  t h h t t t th  a WDhGDGt  t t  ~ htH  aht  G h h h h tN  ht  h h h 
Figure 8. PKD Domains 
These domains are present in exons 5, 13, 14, and 15. Other proteins that contain PKD domains are also listed, such as human and bovine 
melanoma ntigen Pme117, human Nmb protein, Clostridium perfringens collagenase, four domains of the Methanothermus fervidus SIpb protein, 
and Achromobacter lyticus protease (API). The hydrophobic and turn-like or polar amino acids are denoted by h and t, respectively. Conserved 
amino acids are represented inthe bottom line of the figure. 
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C-LECT 387 
C~st ein~Rich do~i~ / / z~I 
NH2 H 
Figure 9. A Schematic Representation ofthe PKD1 Protein 
The figure depicts the location of the LRRs, flanked by cysteine-rich domains, the C-lectin domain (C-LEC), the LDL-A domain, and the fourteen 
PKD domains represented by numbers. The amino acid sites for predicted cysteine disulfide bonds in the C-lectin domain are identified with 
arrows. The cysteines represented by the numbers 298, 387, 401, and 409 should be represented instead by the numbers 419, 507, 522, and 
530. The carboxyl half of the protein has no identifiable domains. 
forms of cystic disease, including ADPKD. The structure of 
PKD1 protein makes it unlikely that the primary defect in 
ADPKD involves a growth factor or classical receptor- 
mediated signal transduction pathway. 
A number of reports have suggested that defects in ex- 
tracellular matrix components or cell-matrix interactions 
are involved in the pathogenesis of ADPKD (Haverty and 
Neilson, 1988). First, it is known that the ADPKD pheno- 
type encompasses nonrenal abnormalities uch as vascu- 
lar aneurysms and cardiac valve defects (Gabow, 1990). 
These abnormalities are also prominent features of dis- 
eases such as Ehlers-Danlos syndrome and Marfan syn- 
drome that result from mutations in extracellular matrix 
components such as collagen and flbrillins (Kontusaari et 
al., 1990; Tsipouras et al., 1992). Analysis of ADPKD tis- 
sue reveals variably thickened basement membrane with 
decreased amounts of proteoglycans and increased 
amounts of fibronectin relative to those of normal individu- 
als (Carone et al., 1989). A well-studied rodent model of 
acquired cystic disease provides further evidence that ex- 
tracellular matrix abnormalities are involved in cyst forma- 
tion (Butowski et al., 1985). 
One hypothesis linking extracellular matrix abnormali- 
ties and ADPKD postulated that the mechanical compli- 
ance of the tubular basal membrane is altered, allowing 
tubules to distend (Welling and Grantham, 1972). How- 
ever, in this study, altered elasticity in cystic tubules was 
not detected. A second hypothesis relies on a growing 
body of evidence that the extracellular matrix influences 
the development and morphology of the cells in contact 
with it (Rodriguez-Boulan and Nelson, 1989). The extracel- 
lular matrix interacts with the cell cytoplasm through cell 
adhesion molecules known as integrins (Hynes, 1992). 
During normal tubular development, coordinated interac- 
tions between the extracellular matrix and epithelial cells, 
mediated by cell-extracellular matrix adhesion, are critical 
for tubular morphogenesis. These interactions lead to a 
specific pattern of gene expression that in turn results 
in normal cell differentiation. Cell differentiation in turn 
modulates the synthesis of matrix components. 
Our data suggest that the PKD 1 protein presents several 
adhesive domains to the extracellular space. We hypothe- 
size that these domains bind matrix or cell membrane- 
associated ligands, and that these interactions mediate 
normal epithelial differentiation. One property of the differ- 
entiated state is the maintenance of tubular architecture 
and an epithelial cell morphology that is appropriate for 
each tubular segment. Mutation of the PKD1 protein leads 
to failure of these interactions, so that epithelial differentia- 
tion does not occur or is not maintained. 
The abnormal state of differentiation accounts for the 
range of features of the ADPKD phenotype; although cyst- 
lining cells are arranged in a monolayer and have well- 
defined tight junctions and other features of a differenti- 
ated epithelium, gene expression is abnormal for a mature 
epithelium (Carone et al., 1993). Epithelia fail to acquire, 
or maintain, critical properties of the differentiated state, 
such as the synthesis of extracellular matrix components 
that define the mature tubular basement membrane 
(Klingel et al., 1993; Dvergsten et al., 1994). The increased 
cell proliferation and occasional micropolyp formation 
seen in ADPKD (Evan et al., 1979) also reflect a less devel- 
oped state. Another characteristic of cystic epithelium that 
more closely resembles the undifferentiated state is the 
distribution of cell membrane markers: the apical location 
of Na+/K ÷ ATPase, for example, is similar in cystic and 
fetal kidneys. 
A number of experimental approaches can be used to 
test the hypotheses that arise from our predicted protein. 
First, antibodies raised against the PKD1 protein can be 
used to determine the cellular localization of the protein 
and will also help to dissect the molecules interacting with 
the extracellular domains of the protein. Second, these 
antibodies may block interactions in cell culture, where 
properties such as cell adhesion, cell polarity, synthesis 
of matrix components, and morphology could be as- 
sessed. A cell culture approach has been used success- 
fully to determine the functions of integrins (Ruoslahti and 
Pierschbacher, 1987). identification of the PKD1 protein 
ligands will allow the definition of the pathways that lead 
to normal epithelial morphogenesis. 
Further study is also needed to determine the spectrum 
of mutations and the basis for the dominant inheritance 
of ADPKD. The distribution of mutations reported to date 
is biased by the relative ease of analyzing the unique 3' end 
of the PKD1 gene. The great majority of PKD1 mutations 
remain uncharacterized and may be distributed through- 
out the gene. The genomic sequence did not provide clues 
that might account for the high new mutation rate observed 
in PKD1 (Snarey et al., 1994). The intron/exon structure 
reported here will expedite the analysis of mutations in 
the duplicated part of the PKD1 gene. 
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ADPKD is on ly  one  of  many genet ic  fo rms of  renal  cystic 
d isease.  Mutat ions  in at least f i f teen nonal le l ic  loci in hu- 
man and mouse  have been shown to cause  the d i sease  
(Reeders ,  1992; Calvet,  1994). It is c lear  that  a large num- 
ber  of  genes,  involved in one  or more  b iochemica l  path- 
ways,  are respons ib le  for mainta in ing normal  tubular  mor-  
phology.  Determinat ion  of  the structure o f  the PKDI  gene 
and its protein prov ides  an important  entry  point for the 
dissect ion of  these  pathways.  
Experimental procedures 
Genomic Clones 
The P1 phage named PKD 1521 was obtained from a human genomic 
library (Genome Systems, St. Louis, MO) and was isolated by use of 
primers from both the 5' end of the TSC2 gene and the 5' end of KG8. 
The cosmid cGGG10 has been described (Germino et al., 1992). A 
random library of the cosmid was constructed by cloning sheared DNA 
fragments into the Smal site of pUC 19. Initial sequence assembly for 
the cosmid cGGG10 was performed with forward and reverse se- 
quences from approximately 1000 random cloned fragments. A prelim- 
inary map was constructed by using the restriction map of the cosmid. 
Directed subclones of cGGG10 were made in pBluescript in order to 
create sequencing islands anchored to specific restriction enzymes. 
These large subclones from cGGG10 were then restricted with more 
frequent cutter enzymes and cloned into M13mp19 and mp18. Di- 
rected sequencing employing primer walks to form large anchored 
contigs was also performed by using the appropriate subclones of 
cGGG10. A contig of 34.3 kb was constructed, with two gaps that 
contain highly repetitive regions with no identifiable coding sequence. 
cDEB11 has been described (Germino et al., 1992). A random library 
was constructed with sheared cDEB11 DNA and cloned into the Smal 
site of pUC 19. This cosmid was sequenced to obtain at least 2-fold 
coverage. 
The products of cycle sequencing were separated on automated 
sequencers (Applied Biosystems, Incorporated) according to the in- 
structions of the manufacturer, with modifications described below. 
Because of the difficulty of sequencing certain regions, the standard 
chemistry needed to be modified. We used both dye terminator and 
dye primer methods when appropriate for sequencing different re- 
gions. We also used a range of polymerasas, different melting temper- 
atures, and polymerization conditions to optimize the quality of the 
sequence. When sequencing across the CpG island at the 5' end of 
the PKD1 gene, we obtained the best sequencing results by adding 
5% dimethyl sulfoxide to the polymerization step and sequencing sin- 
gle-stranded templates. 
cDNA Library Screening 
cDNA clones were identified in two ways. First, fragments of cosmids 
cGGG10 and cDEB11 were hybridized to five cDNA libraries 
(lymphoblast, fetal kidney, adult kidney, brain, and teratocarcinoma). 
Second, each cDNA clone was hybridized to fetal kidney and lympho- 
cyte cDNA libraries to obtain overlapping clones to extehd the se- 
quence. The first cDNA used to screen libraries was KG8, which maps 
to the unique region of the PKD1 locus and was recovered from an 
adult lymphocyte library. To obtain the rest of the PKD1 transcript, 14 
new cDNAs were sequenced to completion, 4 cDNAs were partially 
sequenced, and an additional 20 cDNAs were mapped with respect 
to cGGG10. Additional data were obtained from polymerase chain 
reaction (PCR) products of the renal cell carcinoma library as a tem- 
plate (American Type Culture Collection). 
Overlapping partial cDNAs described below were isolated from lym- 
phocyte and fetal kidney libraries. In this way, we assembled a 14.5 
kb transcript starting from the 3' end until we reached the CpG island. 
We assumed we had reached the 5' end of the transcript, not only 
because of the presence of the CpG island, but because three cDNAs 
isolated (UN53, UN54, and UN59, described below) all had the same 
5' end. No further upstream clones were recovered upon further 
screening (with UN53) the libraries that provided most of the cDNAs 
used to build the full-length cDNA. 
FK7 and FK11 were recovered from a 14-16 week fetal kidney cDNA 
library by using KG8. This library was oligo(dT) primed and constructed 
with the Superscript Lambda System (GIBCO BRL). FK7 and FK11 
were recovered as Sail inserts. BK156, BK194, and UN49 and UN52 
were recovered from a Jurkat library by using FK7 as a probe. 
UN34 was recovered from the same library by hybridizing a ScaI-Sall 
probe from the 5' end of FK7. UN53, UN54, and UN59 were recovered 
from the same library by double screening for clones that were both 
negative when probed with an FK7 and positive when screened with 
BK156 and UN52. This Jurkat library was a gift of the laboratory of 
M. Owen at the Imperial Cancer Research Fund. NKG11 was recov- 
ered from a lymphocyte library screened with cGGG10 and has been 
described previously (Germino et al., 1992). Fhkb21 was isolated from 
a fetal kidney library by using BK156 as a probe (Clontech). MSK3 
was obtained by probing an adult kidney library (CIontech) with the 
5' end of KG8. MSK4 was obtained by nested reverse transcription- 
PCR with primers spanning from exons 7 to 8 and exons 13 to 14, 
followed by a second round of PCR with internal primers in exons 8 
and 13. 
cDNA Sequencing 
The cDNAs were sequenced to 5-fold coverage by primer walking 
and by subcloning small fragments into M13 or pBluescript. All cDNA 
sequences were compared with cGGG 10 sequence to assess whether 
they were from the correct locus and to determine intron/exon bound- 
aries. Regions of discrepancy were sequenced again to determine 
whether the differences were genuine. Some of the cDNAs described 
above were unequivocally different from the genomic sequence (more 
than 3 bp difference for every 100 bp), suggesting that these cDNAs 
were encoded by another locus. 
MSK3, FKT, and FK11, obtained by using a PKDl-specific probe 
(KG8), were found to be 100% identical to the genomic sequence. 
UN49 showed 99% identity and is possibly PKD1 specific. BIC?.41, 
BK194, UN52, UN53, UN54 and UN59, BK156, Fhkb21, and NKG11 
were 97O/o-98% homologous to the cGGG10-defined exon sequence 
and therefore were assumed to have originated from the duplicated 
loci. In general, differences between genomic and cDNA sequences 
were nucleotide substitutions scattered throughout the cDNA se- 
quence. One exception is BK194, which has an extra CAG at position 
1863 of the published sequence and arose from alternative splicing 
of exon 33. Another exception is BK241, which has a tandem repeat 
of TTATCAATACTCTGGCTGACCATCGTCA inserted at position 
1840 of the previously published sequence (European Polycystic Kid- 
ney Disease Consortium, 1994) and was not included in the full-length 
cDNA because it arose from a duplicated locus. Except for BK241, 
cDNAs in the UN and BK series that overlap each other are more 
similar to themselves than to the cGGG10 sequence. 
All sequence assembly was performed by using the Staden pack- 
age, XBAP (Dear and Staden, 1991). 
Protein Homology Searches 
The PKD1 sequence was subjected to a number of sequence analysis 
approaches (Koonin et al., 1994; Bork et al., 1994). To identify homo- 
logs, initial (SwissProt, PIn, GenPept, TREMBL, EMBL, GenBank, 
and NRDB) database searches were performed by use of the BLAST 
series of programs (Altschul and Lipman, 1990) by applying a filter 
for compositionally biased regions (Altschul et al., 1994). By default, 
the BLOSUM62 amino acid exchange matrix was used (Henikoff and 
Henikoff, 1993). To detect additional candidate proteins that might be 
homologous to PKD1, the BLOSUM45 and PAM240 matrices were 
also applied. Putative homologs with a BLAST p value below 0.1 
were studied in detail. Multiple alignments of the candidate domains 
were carried out using CLUSTALW (Thompson et al., 1994), and pat- 
terns (Rohde and Bork, 1993), motifs (Tatusov et al., 1994), and pro- 
files (Gribskov et al., 1987) were derived. With all these constructs, 
iterative database searches were performed. Results of these data- 
base searches were used for improving the multiple alignments that 
were then used for the next round of database searches. The final 
multiple alignment, containing all retrieved members of a module fam- 
ily, was then used as input for the secondary structure predictions 
(Rost and Sander, 1994). 
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